Blog - Page 3287 of 5748

MondayApr 16, 2012 8:52 am

RF Monolithics, Inc. (RFMI) Reaches Agreement to Be Acquired by Murata Electronics North America, Inc.

RF Monolithics, an industry leader in machine-to-machine (M2M) wireless communications, announced today that it has reached an agreement to be acquired by Murata Electronics North America for $1.78 per share to holders of RFM common shares. This price provides an 80% premium over the Nasdaq closing price as of April 12, 2012. The acquisition is scheduled to close during the third calendar quarter of 2012. Murata Manufacturing Co., Ltd, the parent company of Murata Electronics North America, is the world’s premier supplier of passive electronic components. The executives at RF Monolithics believe that this agreement will bring a significant premium…

FridayApr 13, 2012 3:14 pm

FluoroPharma Medical, Inc. (FPMI) Takes On the CAD Stress Test

FluoroPharma, a developer of imaging agents used in association with positron emission tomography (PET) scanning, was founded in 2003 by Dr. David Elmaleh, currently the company’s Chief Scientific Officer, who has gathered around him some of the most knowledgeable people in the radiopharmaceutical and medical technology industries. Together they are developing a protected portfolio of PET tracer agents, including their lead products, CardioPET, BFPET, and VasoPET, designed for use in evaluating different processes associated with coronary artery disease (CAD), the country’s #1 killer. Nearly one-third of all Americans are believed to have some form of cardiovascular disease. People with CAD…

FridayApr 13, 2012 3:12 pm

VLOV, Inc. (VLOV) Posts Solid Q4, FY2011 Financial Performance

VLOV, a men’s lifestyle apparel designer in the People's Republic of China, today announced its financial results for the three and 12 months ended December 31, 2011, reflecting record revenue and increased brand awareness. (All amounts in thousands, in U.S. dollars, except for percentages). The company reported full year 2011 net sales at $88,826, an increase of 20.3 percent compared with net sales of $73,834 reported for 2010. Total cost of sales for 2011 was $50,064, an increase of 18.1 percent compared to total cost of sales of $43,863 reported for the comparable 12 months of 2010. Cost of sales…

FridayApr 13, 2012 2:18 pm

SmallCapVoice: Marley Coffee (JAMN) to Unveil Dynamic New Products at NAMA OneShow in Las Vegas

Marley Coffee, a sustainably grown, ethically farmed and artisan roasted gourmet coffee, today announced the company will exhibit at the National Automatic Merchandising Association (NAMA) OneShow at the Venetian/Sands in Las Vegas, April 25-27, Booth #447. The 2012 NAMA OneShow is the essential event that showcases everything new in vending, coffee service and foodservice. During NAMA OneShow, Marley Coffee will showcase two significant new product offerings aimed at increasing penetration in the vending, foodservice and coffee service sectors. Details will be announced the week of April 22, prior to the start of NAMA OneShow. In addition, the company will showcase…

FridayApr 13, 2012 12:40 pm

InVivo Therapeutics Holdings Corp. (NVIV) Closer to Commencing Human Study for Treatment of Spinal Cord Injuries

InVivo Therapeutics Holdings, a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today detailed results of its meeting with the U.S. Food and Drug Administration (FDA) for discussion of the investigational device exemption (IDE) previously filed for InVivo’s biopolymer scaffolding for the treatment of acute spinal cord injuries. Before InVivo can advance to human clinical studies, the FDA must approve the company’s IDE filing, for which the FDA has agreed to an open dialogue as the application moves toward gaining approval. Following the meeting, the company said it anticipates that the biopolymer scaffolding device will be…

FridayApr 13, 2012 11:57 am

Genetic Technologies Ltd. (GENE) Gives Update on Its Subsidiary

Genetic Technologies is a pioneer in recognizing important new applications for “non-coding” DNA. The company has been granted patents in 24 countries around the world, securing intellectual property rights for uses of non-coding DNA in genetic analysis and gene mapping. Its strategy is to globally commercialize its patents through a licensing program and expansion of its diagnostic portfolio. The company announced today that its privately-held subsidiary, ImmunAid Pty. Ltd., has successfully obtained 1 million Australian dollars in a private placement from investors located in Australia, Europe, and the United States. In return for this investment, the investors have secured a…

FridayApr 13, 2012 8:24 am

Hooper Holmes, Inc. (HH) Launches iParamed 2.0, Enabling Health Professionals to Conduct Exams Virtually Anywhere in the U.S.

Hooper Holmes, a leading provider of health risk assessment services for the insurance and healthcare industries, announced today it has officially launched iParamed 2.0. This electronic exam with built-in completion technology allows the company’s nationwide network of health professionals to conduct electronic paramedical exams in locations where there is little or no cellular service. With a booming demand for electronic exams, health professionals nonetheless have to conduct exams at the homes or offices of life insurance applicants – often in areas where there is a weak or nonexistent wireless signal. To guarantee greater use of electronic exams, Hooper Holmes elected…

FridayApr 13, 2012 8:20 am

Golfsmith International Holdings, Inc. (GOLF) Opens Experimental Store in Maryland

Yesterday, Golfsmith International Holdings unveiled its newest Golfsmith retail location in Baltimore, MD. The location is Golfsmith's 83rd store, but the chain's first location in Maryland. The store will offer golf enthusiasts high-tech simulators, coaching sessions, and opening-weekend offers. Golfsmith International Holdings is a specialty retailer of golf and tennis equipment, as well as apparel and accessories for the sports, with a 45-year history. The company offers premier golfing equipment by brand names, as well as its own lines of proprietary merchandise, as well as pre-owned equipment. Some of the amenities offered by the new retail location include the ability…

FridayApr 13, 2012 8:18 am

U.S. Trade Deficit Falls; American Exports Rise

On Thursday, reports emerged announcing that the U.S. trade deficit fell in February to its lowest point in four months. According to the Commerce Department, the trade deficit decreased 12.4 percent to $46 billion in February, down from $52.5 billion in January. Some predict that the narrower deficit could lead economists to revise their growth estimates for the 1st quarter of 2012. Most economists have predicted that growth slowed in the January-March quarter to an annual rate of less than 2.5 percent, down from 3 percent at the end of last year. "February's U.S. trade data are better than expected…

ThursdayApr 12, 2012 3:42 pm

Northwest Biotherapeutics, Inc. (NWBO) Partners with King’s Health Partners to Benefit Ongoing Clinical Trial

Northwest Biotherapeutics, a biotech company focused on the development of immunotherapy products for the treatment of cancers, today announced its partnership with King's Health Partners, in which the companies will manufacture and deliver a new treatment for patients with brain cancer as part of its ongoing 240-patient clinical trial for Glioblastoma multiforme (GBM), the most fatal form of brain cancer. Per the arrangement, specialists at King's College London will manufacture Northwest’s immune therapy treatment, DCVax®, for the clinical trial, which will take place at King's College Hospital NHS Foundation Trust in London. Among several anticipated benefits, the collaboration generates additional…

Site Search

Company Search